Tumor-Specific Cytotoxic T Lymphocyte Responses against Chondrosarcoma with HLA Haplotype Loss Restricted by the Remaining HLA Class I Allele
- 31 August 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 286 (4) , 786-791
- https://doi.org/10.1006/bbrc.2001.5411
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer AntigensImmunity, 1999
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- A new HLA–DQB 1*0306 allele sharing motifs from DQB 1*03032 and DQB1*04 sequencesTissue Antigens, 1996
- Chondrosarcoma of the pelvis: Prognostic factors for 67 patients treated with definitive surgeryCancer, 1996
- Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell lineTissue Antigens, 1996
- Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Natural history of HLA expression during tumour developmentImmunology Today, 1993
- Polymerase-chain-reaction-based analysis of polymorphism in the HLA-B geneHuman Immunology, 1992
- Tumorigenicity in Human Melanoma Cell Lines Controlled by Introduction of Human Chromosome 6Science, 1990